Navigation Links
Improving care and knowledge in translational research to fight breast cancer
Date:4/15/2008

Berlin, 15 April 2008 -- European breast cancer specialists have taken a significant step forward in the fight against breast cancer by bringing together world leaders in breast cancer research and treatment at an innovative European scientific meeting, IMPAKT (IMProving cAre and Knowledge in Translational research).

The first IMPAKT meeting, to be held 7-9 May 2009 in Brussels, Belgium, is designed to present and discuss advances in translational research and ways to quickly transform laboratory discoveries into tools that clinicians can use to help make decisions about the way they treat patients in their daily practice.

With breast cancer being the most prevalent cancer in women worldwide, collaboration to fight this devastating disease is necessary. IMPAKT fills an urgent need within the oncology community to coordinate efforts to bring the fruits of advances in science and technology to the patients bedside, says Dr. Martine Piccart, Co-Chair of the meeting.

Building on existing high-level international research collaborations developed by the Breast International Group (BIG) and combining this with the other partners reputations for organizing high quality scientific and educational meetings, IMPAKT will offer a platform for discussing the latest developments in translational research, biomedical technologies and novel therapeutics in breast cancer, adds Dr. Jos Baselga, conference Co-Chair with Dr. Piccart.

IMPAKT is being launched by BIG and the European Society for Medical Oncology, in collaboration with the St. Gallen Primary Therapy of Early Breast Cancer Conference; the three European Breast Cancer Conference partners, which are The European Organisation for Research and Treatment of Cancer Breast Cancer Group, The European Society of Breast Cancer Specialists, and Europa Donna The European Breast Cancer Coalition; and with the support of the European School of Oncology.

We have succeeded in creating a model of direct collaboration between professional medical societies, research groups and cancer patient organizations. This underlines the IMPAKT organizers commitment to stimulate much needed communication across basic, translational and clinical research in breast cancer, said Dr. Baselga.

The meeting will encourage researchers and clinicians to share best practices and provide participants with information on the skills and techniques needed today to apply cutting-edge research to the clinical setting.

While IMPAKT is primarily a scientific meeting, it also includes a full-day training course for young oncologists to help them better understand the new translational research technologies. They will also gain insights into future opportunities in research, and have the possibility to link up with the international network of breast cancer experts.


'/>"/>

Contact: Gracemarie Bricalli
communication@esmo.org
41-079-778-5177
European Society for Medical Oncology
Source:Eurekalert

Related biology news :

1. Improving detection of nuclear smuggling goal of computer model of mechanical engineer
2. UV light improving chances of fighting cancer
3. Improving science, technology in Africa is aim as G-8, African, UN experts convene in Berlin
4. A tall story: New research adds to growing body of knowledge of genetics of height
5. A call to infuse scientific knowledge into the human experience
6. Rutgers scientists research reveals critical knowledge about the nervous system
7. UD hosts conference on knowledge-based partnerships Nov. 2
8. Fossil data plugs gaps in current knowledge, study shows
9. Translational research patented first experimental treatment against idiopathic pulmonary fibrosis
10. AACR, BCRF award inaugural grants in translational breast cancer research
11. NIH awards nearly $23M to University of Chicago for translational research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks , ... industrial engineering, was today awarded as one of ... of the world,s most innovative companies. Ginkgo Bioworks ... for the real world in the nutrition, health ... work directly with customers including Fortune 500 companies ...
(Date:6/24/2016)... Raleigh, NC (PRWEB) , ... June 24, 2016 , ... ... find the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings ... here to read it now. , Diagnostic biomarkers are signposts in the blood, ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology: